Covered recipient · General Payments record
KAYLA K HERRON
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,120.20
- Reported across 115 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $309.55 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $75.57 | 3 |
| Incyte Corporation | $61.90 | 3 |
| Amgen Inc. | $61.66 | 3 |
| ABBVIE INC. | $34.51 | 2 |
| UCB, Inc. | $31.18 | 2 |
| Galderma Laboratories, L.P. | $17.36 | 1 |
| IBSA Pharma Inc. | $13.95 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $13.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.37 | 05/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107327234 | CMS |
| ABBVIE INC. | $21.14 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107327236 | CMS |
| Amgen Inc. | $22.78 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117577902 | CMS |
| Amgen Inc. | $20.51 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117577904 | CMS |
| Amgen Inc. | $18.37 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117577906 | CMS |
| Galderma Laboratories, L.P. | $17.36 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145363757 | CMS |
| IBSA Pharma Inc. | $13.95 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142979179 | CMS |
| Incyte Corporation | $20.71 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141207403 | CMS |
| Incyte Corporation | $20.06 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141283667 | CMS |
| Incyte Corporation | $21.13 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141284187 | CMS |
| Regeneron Healthcare Solutions, Inc. | $25.38 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114314959 | CMS |
| Regeneron Healthcare Solutions, Inc. | $24.48 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114314961 | CMS |
| Regeneron Healthcare Solutions, Inc. | $25.71 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114314963 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $13.42 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152245445 | CMS |
| UCB, Inc. | $17.16 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143471736 | CMS |
| UCB, Inc. | $14.02 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143471741 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.